ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,073 | -73.9% | 15,731 | +1.0% | 0.00% | – |
| Q2 2023 | $7,941 | -24.4% | 15,570 | -6.6% | 0.00% | – |
| Q1 2023 | $10,500 | -18.6% | 16,667 | -16.2% | 0.00% | – |
| Q4 2022 | $12,906 | -58.4% | 19,883 | +9.3% | 0.00% | – |
| Q3 2022 | $31,000 | +47.6% | 18,186 | +8.1% | 0.00% | – |
| Q2 2022 | $21,000 | -48.8% | 16,818 | -72.7% | 0.00% | – |
| Q1 2022 | $41,000 | -50.6% | 61,668 | -19.1% | 0.00% | – |
| Q4 2021 | $83,000 | -37.6% | 76,236 | +4.6% | 0.00% | – |
| Q3 2021 | $133,000 | -45.9% | 72,914 | -21.7% | 0.00% | -100.0% |
| Q2 2021 | $246,000 | -21.2% | 93,105 | +7.5% | 0.00% | 0.0% |
| Q1 2021 | $312,000 | +54.5% | 86,618 | +7.9% | 0.00% | 0.0% |
| Q4 2020 | $202,000 | +206.1% | 80,295 | +207.3% | 0.00% | – |
| Q3 2020 | $66,000 | -30.5% | 26,132 | -9.8% | 0.00% | -100.0% |
| Q2 2020 | $95,000 | +265.4% | 28,973 | +168.2% | 0.00% | – |
| Q1 2020 | $26,000 | -74.8% | 10,803 | -50.4% | 0.00% | – |
| Q4 2019 | $103,000 | +32.1% | 21,763 | +19.0% | 0.00% | – |
| Q3 2019 | $78,000 | -3.7% | 18,285 | +31.2% | 0.00% | – |
| Q2 2019 | $81,000 | +47.3% | 13,941 | -2.6% | 0.00% | – |
| Q1 2019 | $55,000 | +111.5% | 14,307 | +3.2% | 0.00% | – |
| Q4 2018 | $26,000 | -50.0% | 13,861 | -13.9% | 0.00% | – |
| Q3 2018 | $52,000 | 0.0% | 16,096 | -7.1% | 0.00% | – |
| Q2 2018 | $52,000 | -21.2% | 17,331 | +3.2% | 0.00% | – |
| Q1 2018 | $66,000 | -18.5% | 16,794 | -13.9% | 0.00% | -100.0% |
| Q4 2017 | $81,000 | +12.5% | 19,505 | +68.0% | 0.00% | 0.0% |
| Q2 2017 | $72,000 | -19.1% | 11,608 | -17.0% | 0.00% | 0.0% |
| Q1 2017 | $89,000 | -14.4% | 13,990 | -28.3% | 0.00% | 0.0% |
| Q4 2016 | $104,000 | +52.9% | 19,522 | +62.7% | 0.00% | 0.0% |
| Q3 2016 | $68,000 | -17.1% | 12,000 | -19.3% | 0.00% | 0.0% |
| Q2 2016 | $82,000 | -21.2% | 14,863 | +5.9% | 0.00% | 0.0% |
| Q1 2016 | $104,000 | -25.2% | 14,040 | -15.9% | 0.00% | -50.0% |
| Q4 2015 | $139,000 | +41.8% | 16,696 | +52.7% | 0.00% | +100.0% |
| Q3 2015 | $98,000 | -43.7% | 10,932 | -24.5% | 0.00% | -50.0% |
| Q2 2015 | $174,000 | -7.9% | 14,484 | -17.5% | 0.00% | 0.0% |
| Q1 2015 | $189,000 | +114.8% | 17,546 | +0.7% | 0.00% | +100.0% |
| Q4 2014 | $88,000 | +3.5% | 17,432 | -46.0% | 0.00% | 0.0% |
| Q3 2014 | $85,000 | -46.5% | 32,256 | -18.5% | 0.00% | -50.0% |
| Q2 2014 | $159,000 | -57.4% | 39,561 | -51.4% | 0.00% | -60.0% |
| Q1 2014 | $373,000 | +122.0% | 81,441 | +92.0% | 0.01% | +25.0% |
| Q3 2013 | $168,000 | +84.6% | 42,407 | -2.0% | 0.00% | +100.0% |
| Q2 2013 | $91,000 | – | 43,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |